This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Morinaga Milk Industry Co., Ltd.. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Yasuhito Terui: Innovator in Cancer Therapy
Introduction
Yasuhito Terui is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer therapy through his innovative research and development. His work focuses on enhancing the efficacy of antibody drugs used in cancer treatment.
Latest Patents
Yasuhito Terui holds a patent for a drug designed for cancer therapy. This patent involves a lactoferrin hydrolysate mixture or lactoferrin partial peptide that is obtained by hydrolyzing lactoferrin with a hydrolytic enzyme. The active ingredient enhances the cytotoxic activity of an antibody drug in antibody therapy for cancer.
Career Highlights
Terui is associated with Morinaga Milk Industry Co., Ltd., where he applies his expertise in developing therapeutic solutions. His innovative approach has led to advancements in cancer treatment methodologies.
Collaborations
He has collaborated with notable colleagues, including Kiyohiko Hatake and Yuji Mishima, to further enhance the research and development of cancer therapies.
Conclusion
Yasuhito Terui's contributions to cancer therapy through his innovative patent demonstrate his commitment to improving treatment options for patients. His work continues to inspire advancements in the medical field.